文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

年龄、可溶性髓样细胞触发受体-1(sTREM-1)与危重症成人死亡率的关系:一项队列研究

Relationships Between Age, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), and Mortality Among Critically Ill Adults: A Cohort Study.
PubMed 文献 · Shock · 2022-01-01
一句话结论危重症成人中,年龄>50岁者sTREM-1较高,sTREM-1升高与28天死亡和持续器官功能障碍风险增加相关。

这项前瞻性队列研究在一家大型三级医院的内科和创伤外科ICU纳入231例危重症成人,入ICU 24小时内测血浆sTREM-1。年龄>50岁(n=122)与sTREM-1浓度升高27%(95%CI 6%-53%)相关,校正性别和Charlson共病指数(CCI)。sTREM-1每升高2倍,28天死亡风险增加2.42倍(95%CI 1.57, 3.73),持续器官功能障碍风险增加1.86倍(95%CI 1.45, 2.39),校正性别、CCI和年龄。作者认为sTREM-1相关免疫反应可能参与ICU结局的年龄差异,有待进一步研究作为老年患者的潜在治疗靶点。

要点

  • 年龄>50岁的危重症患者sTREM-1浓度较≤50岁者高27%(95%CI 6%-53%),校正性别和CCI。
  • sTREM-1每升高2倍,28天死亡风险增加2.42倍(95%CI 1.57, 3.73),校正性别、CCI和年龄。
  • sTREM-1每升高2倍,持续器官功能障碍(需透析、血管活性药或无创机械通气)风险增加1.86倍(95%CI 1.45, 2.39)。
  • 持续器官功能障碍定义为入ICU后7天需透析、血管活性药或机械通气。
  • 年龄>50岁组慢性病和脓毒症患病率更高,但急性疾病严重程度相似。

适用人群与场景

  • 一家大型三级医院内科和创伤外科ICU收治的成人危重症患者,共231例;年龄>50岁组n=122。
  • 入ICU 24小时内测量血浆sTREM-1。

诊断标准与关键阈值

  • 持续器官功能障碍定义为入ICU后7天需要透析、血管活性药或机械通气。

研究设计与关键结果

  • 前瞻性队列研究,纳入231例危重症成人,来自一家大型三级医院的内科和创伤外科ICU。
  • 年龄>50岁与sTREM-1浓度升高27%相关(95%CI 6%-53%),校正性别和Charlson共病指数(CCI)。
  • sTREM-1每升高2倍与28天死亡风险增加2.42倍相关(95%CI 1.57, 3.73),校正性别、CCI和年龄。
  • sTREM-1每升高2倍与持续器官功能障碍风险增加1.86倍相关(95%CI 1.45, 2.39),校正性别、CCI和年龄。
  • 年龄>50岁患者(n=122)慢性病和入组时脓毒症患病率高于年轻患者,但急性疾病严重程度相似。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为sTREM-1相关免疫反应可能参与ICU结局的年龄差异,有待进一步研究作为老年患者的潜在治疗靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Innate immune dysregulation may contribute to age-related differences in outcomes among critically ill adults. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is an important innate immune marker with prognostic value in sepsis, but age-related differences have not been studied.

METHODS: This was a prospective cohort from a large tertiary care hospital enrolling adults from both medical and trauma-surgical intensive care units (ICUs). Plasma sTREM-1 was measured in participants within 24 h of ICU admission. We analyzed associations between age (≤50 and >50 years) and sTREM-1 using linear regression. We then examined associations between sTREM-1 and both 28-day mortality and persistent organ dysfunction (defined as need for dialysis, vasopressors, or invasive mechanical ventilation) 7 days following admission using relative risk regression.

RESULTS: Of 231 critically ill adults, older patients (n = 122) had higher prevalence of chronic disease and sepsis on enrollment than younger patients, but acute illness severity was similar. Age over 50 was associated with 27% higher sTREM-1 concentrations (95% CI 6%-53%), adjusted for sex and Charlson comorbidity index (CCI). Two-fold higher sTREM-1 was associated with 2.42-fold higher risk for mortality (95% CI 1.57, 3.73) and 1.86-fold higher risk for persistent organ dysfunction (95% CI 1.45, 2.39), adjusted for sex, CCI, and age.

CONCLUSIONS: sTREM-1 was elevated among critically ill older adults, and strongly associated with both death and persistent organ dysfunction. Immune responses associated with sTREM-1 may contribute to age-related differences in ICU outcomes, warranting further study as a potential therapeutic target in older adults.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Sathe NA, Bhatraju PK, Mikacenic C, et al. Relationships Between Age, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), and Mortality Among Critically Ill Adults: A Cohort Study. Shock. 2022. PMID: 34812186. doi:10.1097/SHK.0000000000001888

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。